SHM: The application for the listing of acetic acid leuprolide chemical raw materials has been approved
I'm PortAI, I can summarize articles.
Sichuan Shuangma's subsidiary Hubei Jianxiang Biopharmaceutical Co., Ltd. recently received approval from the National Medical Products Administration to market the chemical raw material drug Acetate Leuprolide. This drug is a Gonadotropin-Releasing Hormone (GnRH) agonist, primarily used for the treatment of endometriosis, uterine fibroids, prostate cancer, and other diseases
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments